Certara Announces New Release of Integral® Software
Latest version enhances efficiency, compliance, and user experience for PK scientists Radnor, PA. — December…
Danielle PillsburyDecember 16, 2025
Accelerated ADC Approval Through Expert Modeling and Data Rescue
See how Certara rescued complex ADC PK datasets, delivered PopPK, exposure-response modeling, and enabled rapid…
CertaraDecember 15, 2025
Pharmacokinetic and bioequivalence of two formulations of Valsartan/Amlodipine Tablet(I) in healthy Chinese volunteers: A randomized, three-period, partially replicated crossover study
Discover how randomized crossover study shows new valsartan/amlodipine formulation is bioequivalent to the reference product,…
CertaraDecember 13, 2025
Merck Advances Pediatric Oncology with Innovative ADC Modeling
Merck leveraged ADC modeling and pediatric ADC dose optimization to enable FDA acceptance and advance…
CertaraDecember 12, 2025
How to build standardized eCRFs across multiple EDC systems
Discover how to build standardized eCRFs across multiple EDC systems to improve data quality, accelerate…
CertaraDecember 12, 2025
Certara Appoints Jon Resnick as Chief Executive Officer
Resnick brings decades of leadership experience in health sciences, business operations, strategy, innovation and commercial…
CertaraDecember 11, 2025
New Approach Methodologies (NAMs): By the numbers
We outline today’s animal-use landscape, the rise of NAMs, & how the Non-Animal Navigator supports…
CertaraDecember 10, 2025
New Approach Methodologies: Redefining Animal Testing Alternatives
Explore how New Approach Methodologies (NAMs) and advanced in silico and in vitro tools are…
CertaraDecember 10, 2025
